News
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
Eli Lilly has won a green light from the FDA for new dosing for its Alzheimer's disease therapy Kisunla, which carries a ...
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...
The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...
HATFIELD, HERTFORDSHIRE, UNITED KINGDOM (UK), and MAIDENHEAD, UK, 7 JULY 2025 – Eisai Europe Ltd. and Biogen Idec Ltd. announced today that the Scottish Medicines Consortium (SMC) has not recommended ...
1d
Stocktwits on MSNBiogen Shares Slip After $46M Research Charge Hits Quarterly ProfitBiogen shares slipped on Monday after the company said it expects to take a $46 million charge in the second quarter related ...
The company estimated that more than 1000 women in Scotland at very high risk of fracture would be eligible for treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results